Neurocrine Biosciences

World Rank (Jan-05-2024)

1,326

Market Cap (Jan-05-2024)

13.124 Billion USD

World Rank (Jul-30-2023)

1,672

Market Cap (Jul-30-2023)

10.026 Billion USD

World Rank (Jan-07-2022)

2,475

Market Cap (Jan-07-2022)

7.145 Billion USD

World Rank (Jan-01-2021)

1,837

Market Cap (Jan-01-2021)

8.955 Billion USD

Company Rank in Country in 2023

Rank in USA in July-2023 is 628

Headquarters Country

USA

Nasdaq / NYSE Code

NBIX

Market Cap (Mar-08-2026)

12.86

Employee Count

1,200

Employee Count as of Date

As on 2022

Headquarters City/State

California

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

1,488 Million USD

Annual Operating Income in USD

249 Million USD

Annual Net Income in USD

154 Million USD

Annual Results for Period Ending

Dec-2022 ending year

Total Assets in USD

2,368 Million USD

Total Liabilities in USD

660 Million USD

Total Equity in USD

1,707 Million USD

Balance Sheet for Period Ending

Dec-2022 ending year

Business Sector

Company Website

NEUROCRINE BIOSCIENCES INC

Wikipedia

Yahoo

Yahoo @ Nasdaq

Company Profile

Neurocrine Biosciences is a Neuroscience Focused and Biopharmaceutical company. It is discovering and developing life-changing treatments for people with serious, challenging, under addressed neurological, endocrine and psychiatric disorders. The headquarters is in USA.

Annual Results Summary